Press releases

(July 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its Matrix2™ 360o Detachable Coils, which have been cleared by the U.S. Food and Drug...

(July 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2005 on Tuesday, July 19, at 11:00...

(July 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court jury in Delaware found that Johnson & Johnson's (NYSE: JNJ) CYPHER® drug-eluting stent...

(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...

(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...

(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...

(June 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The...

(June 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the final phase of the acquisition of Rubicon Medical Corporation (OTC BB: RMDC). Boston...

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June 13 -16 in Dana Point, CA....

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson (NYSE: JNJ),...

(June 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of the cash tender offer for any and all outstanding shares of common stock of Rubicon Medical...

(June 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that Lucia Luce Quinn has been appointed Executive Vice President of Human Resources. She will be responsible for...

and Paris, France (May 26, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled its 400th patient in the world

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided updated financial estimates for 2005. The Company announced the estimates at a meeting of financial...

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the efficacy of...

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced thirty-day safety data from its ATLAS clinical trial. ATLAS is the first trial using Boston...

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results from its ARRIVE and Milestone II registries. The results were announced during a symposia...

and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS VI clinical trial. The data demonstrated that the safety and...

and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced intravascular ultrasound (IVUS) follow-up data from its TAXUS V clinical trial, supporting the safety...

and Newton, MA (May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Aspect Medical Systems, Inc. (Nasdaq: ASPM) today announced a strategic alliance in which Boston Scientific will...

(May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of its TAXUS® Express2™...

(May 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR),...

and Chicago, IL (May 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results of four clinical trials demonstrating patient satisfaction with, and effectiveness of, the ENTERYX®

(May 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Banc of America Securities Health Care Conference 2005, which is being held May 17-19 in Las Vegas....

(April 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 30th Annual Health Care Conference, which is being held May 2-4 in Baltimore,...

(April 27, 2005) -- Boston Scientific (NYSE: BSX) today announced one-year data from its carotid artery stenting (CAS) clinical trial known as BEACH. The study evaluates the effectiveness of...

(April 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that six articles related to its pivotal TAXUS IV clinical trial were published in the April 19 edition of the...

(April 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its first quarter ended March 31, 2005. Highlights: Net sales of $1.6 billion, an increase of 49...

(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired TriVascular, Inc., a privately held company based in Santa Rosa, California. Boston Scientific...

(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has exercised its option to acquire CryoVascular Systems, Inc., a privately held company located in Los Gatos,...

(April 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is now acting as the exclusive distributor of the NexStent™ carotid stent and Monorail™ delivery system in...

(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Quincy, Massachusetts Customer Fulfillment Center has received the prestigious 2004 NorthFace ScoreBoardSM...

(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that enrollment has begun in its clinical trial known as SYNTAX, which will compare the performance of drug-eluting...

(April 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the Cadence Management Corporation 2004 Award for Customer Excellence in Project Management. This...

(April 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2005 on Tuesday, April 19, at 11:00...

(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SunTrust Robinson Humphrey's 34th Annual Institutional Conference which is being held April 11-12 at the...

(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for three large vessel sizes (4.0mm, 4.5mm and 5.0mm) of its TAXUS® Express2™...

(April 5, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved enhancements to the Directions for Use (DFU) of the...

(March 29, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the nationwide release of a revolutionary technology to treat chronic, debilitating pain, a condition affecting...

(March 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in Delaware issued a verdict in a retrial of patent litigation between Boston Scientific and Johnson &...

(March 15, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Quincy Distribution Center as a...

(March 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Maple Grove, Minnesota manufacturing facility has received the 2005 Shingo Prize for Excellence in...

(March 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 25th Annual Health Care Conference, which is being held March 14 - 17 at the Marriott...

(March 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its three-year ENTERYX® Procedure clinical trial. The post-approval clinical trial...

and Orlando, FL (March 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Johnson & Johnson's REALITY clinical trial, which reaffirmed the safety and efficacy of...

and Orlando, FL (March 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month results from its TAXUS V clinical trial, confirming the safety and efficacy of the TAXUS®...

(March 4, 2005) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has completed its acquisition of Advanced Stent Technologies, Inc. (AST) of Pleasanton, California, for an...

(March 3, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the American College of Cardiology annual scientific session, which runs...

(February 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the world's largest drug-eluting stent registry. The TAXUS OLYMPIC registry plans to...

(February 22, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its ATLAS clinical trial. ATLAS is the first trial using Boston Scientific's...

(February 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the United Kingdom's National...

(February 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...

and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided financial guidance for 2005 and announced financial goals for 2006 and 2007 at a meeting with...

(January 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed the initial launch of its TAXUS® Liberté™ paclitaxel-eluting coronary stent system. On...

(January 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast the analyst meeting it is hosting on Tuesday, February 1. The meeting is scheduled to begin at 9:00 a.m....

(January 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Piper Jaffray Health Care Conference, which is being held January 25-27 in New York City....

(January 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the implantation of its millionth TAXUS® Express2™ paclitaxel-eluting coronary stent system, marking a major...

(January 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has launched its TAXUS™ Liberté™ paclitaxel-eluting coronary stent system in 18 countries. The TAXUS...

and San Francisco, CA (January 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited sales results for the fourth quarter and for the year ended December...

(January 6, 2005)-- Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. District Court in Delaware has granted summary judgment of non-infringement in favor of Boston...

(January 4, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 23rd Annual JPMorgan Healthcare Conference, which is being held January 10-13 in San Francisco....

and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and for the year ended December 31, 2004 at a meeting with...

(December 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is donating $100,000 to the Red Cross for tsunami relief. The money is being directed to the Red Cross'...

(December 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced an expansion of its management structure designed to position the Company for continued growth and success. The...

(December 16, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into a definitive agreement to acquire Advanced Stent Technologies, Inc. (AST) of Pleasanton,...

(December 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today commented on a ruling by the U.S. District Court for the Southern District of New York on preliminary motions in a breach of...

(November 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Intravascular Ultrasound (IVUS) procedures have been recognized for payment under a new Medicare...

(November 24, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lazard Frères First Annual Life Sciences Conference, which will take place November 30 and...

(November 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it had exercised its right under an existing licensing agreement with Angiotech Pharmaceuticals, Inc. (NASDAQ:...

(November 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the French government that it has added new categories of "high-risk" patients to the...

(November 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its public offering of $250 million aggregate principal amount of its 4.250 percent senior notes...

(November 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has made an equity investment in -- and secured an exclusive option to purchase -- REVA Medical, Inc., a...

(November 15, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today the launch of a public offering of two series of its senior notes under the Company's existing shelf registration...

(November 12, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Credit Suisse First Boston Healthcare Conference 2004, which is being held November 17-19 in...

(November 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Valencia, California, is resuming worldwide distribution of its...

(November 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations at...

(November 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Fifteenth Annual Healthcare Conference, which is being held November 8-10 in...

and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced interim results from a 200-patient clinical trial to evaluate the effectiveness, safety and...

and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of...

and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its ongoing Enteryx Procedure clinical trial for the treatment of...

(November 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical...

(October 28, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has launched a full line of mid-urethral sling products for the treatment of female stress urinary...

(October 27, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE 2 registry program, which plans to enroll 5,000 patients at approximately 60...

(October 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized the repurchase of up to 50 million shares of the Company's common stock...

(October 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2004. Highlights: Net sales of $1.482 billion, an...

(October 13, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary...

(October 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2004 on Tuesday, October 19,...

and Washington, D.C. (October 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting safety from three post-market registries associated with its TAXUS™...

and Washington, D.C. (October 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from its TAXUS V clinical trial. The trial is assessing the slow-release...

and Washington, D.C. (September 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS IV clinical trial. The benefits reported at 12 months...

and Washington, D.C. (September 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS II paclitaxel-eluting stent system clinical trial. The...

(September 28, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it will make a special one-time contribution to the Company's U.S. 401(k) Retirement Savings Plan. All...

(September 24, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Sylmar, California, is voluntarily recalling worldwide all...

(September 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the Transcatheter Cardiovascular Therapeutics (TCT) conference in...

(September 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has completed its inspection of the Company's Galway, Ireland...

(September 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today provided an update on the sales of its TAXUS™ Express2™ paclitaxel-eluting coronary stent systems for the month of August...

(August 31, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced six-month clinical findings from the European component of its Milestone II Registry. The Company said it has...

(August 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that enrollment has begun in its ATLAS clinical trial. ATLAS is the first trial using Boston Scientific's new Liberté™

(August 25, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast a conference call providing updates on its business performance for 2004 and sales of its TAXUS™ Express2™...

(August 25, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Peripheral Cutting...